XML 70 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT AND GEOGRAPHICAL INFORMATION - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Revenue $ 19,552 $ 18,341 $ 17,585
EBIT 2,956 2,861 3,172
Restructuring costs (54) (146) (155)
Acquisition and disposition-related benefits (charges) 15 34 (14)
Gain (loss) on business and asset dispositions 0 1 2
Spin-Off and separation costs (270) (14) 0
Amortization of acquisition-related intangible assets (127) (121) (90)
Investment revaluation gain (loss) 1 (31) 3
Interest and other financial charges – net (542) (77) (40)
Non-operating benefit income (costs) 382 5 (3)
Income from continuing operations before income taxes 2,361 2,512 2,875
Operating segments | Imaging      
Segment Reporting Information [Line Items]      
Revenue 10,581 9,985 9,433
EBIT 1,124 1,100 1,240
Operating segments | Imaging | Radiology      
Segment Reporting Information [Line Items]      
Revenue 8,944 8,395 8,019
Operating segments | Imaging | Interventional Guidance      
Segment Reporting Information [Line Items]      
Revenue 1,637 1,590 1,414
Operating segments | Ultrasound      
Segment Reporting Information [Line Items]      
Revenue 3,457 3,422 3,172
EBIT 821 908 885
Operating segments | PCS      
Segment Reporting Information [Line Items]      
Revenue 3,142 2,916 2,915
EBIT 383 341 356
Operating segments | PCS | Monitoring Solutions      
Segment Reporting Information [Line Items]      
Revenue 2,283 2,092 2,119
Operating segments | PCS | Life Support Solutions      
Segment Reporting Information [Line Items]      
Revenue 859 824 796
Operating segments | PDx      
Segment Reporting Information [Line Items]      
Revenue 2,306 1,958 2,018
EBIT 617 520 693
Other      
Segment Reporting Information [Line Items]      
Revenue 66 60 47
EBIT $ 11 $ (8) $ (2)